DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (2024)

Table of Contents
About DVA Financial Performance Analyst Forecast News Drop Johnson & Johnson, Pick These Steady Eddie Stocks? DaVita Inc. Announces Pricing of $1.0 Billion Senior Notes Offering DaVita Inc. Announces Offering of $1.0 Billion Senior Notes DaVita Inc. 2nd Quarter 2024 Results DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call Renal Denervation Devices Market Expected to Reach USD 387 Million by 2032 with a Remarkable 37.2% CAGR, According to Straits Research US FTC probing DaVita, Fresenius Medical, Politico reports DaVita, Nuwellis Extend Pilot Collaboration for Aquadex DaVita Celebrates Corporate Citizenship Achievements with Release of 2023 Community Care Report DaVita Appoints New Chief Information Officer DaVita Inc. to Participate in the BofA Securities 2024 Health Care Conference DaVita Honors 54 Nephrology Nurses with DAISY Awards DaVita gains after upbeat quarterly profit prompts annual forecast raise DaVita Inc. 1st Quarter 2024 Results Best blue chip healthcare stocks to buy and hold in 2024 DaVita's Global Operations Powered by 100% Renewable Energy DaVita Inc. Schedules 1st Quarter 2024 Investor Conference Call DaVita Announces Dennis Pullin to its Board of Directors The American Diabetes Association and DaVita Strengthen Alliance to Tackle Chronic Disease Head-On DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2024 DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador DaVita Inc. to Participate in the TD Cowen's Health Care Conference 2024 DaVita Stock Is Having Its Best Day in Years. Volumes Are Improving After Covid-19. DaVita gains after co says expects strong 2024 profit DaVita Inc. 4th Quarter 2023 Results FAQs

About DVA

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition... [Read more]

Industry Medical Care Facilities

Sector Healthcare

IPO Date Oct 31, 1995

Employees 70,000

Stock Exchange NYSE

Ticker Symbol DVA

Full Company Profile

Financial Performance

In 2023, DaVita's revenue was $12.14 billion, an increase of 4.57% compared to the previous year's $11.61 billion. Earnings were $691.54 million, an increase of 23.40%.

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for DVA stock is "Hold." The 12-month stock price forecast is $153.6, which is an increase of 3.27% from the latest price.

Price Target

$153.6

(3.27% upside)

Analyst Consensus: Hold

Stock Forecasts

News

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (1)

Drop Johnson & Johnson, Pick These Steady Eddie Stocks?

If you are a Johnson & Johnson investor and have been enjoying the stock's steady dividends, it may be time to look elsewhere. As of this moment, we find DaVita - a healthcare company focused on kidne...

Other symbols: DUKJNJ

7 days ago - Forbes

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (2)

DaVita Inc. Announces Pricing of $1.0 Billion Senior Notes Offering

DENVER , Aug. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita")announced today the pricing of its previously announced private offering (the "offering") of $1.0 billion aggregate principal a...

4 weeks ago - PRNewsWire

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (3)

DaVita Inc. Announces Offering of $1.0 Billion Senior Notes

DENVER , Aug. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita")announced today that it has commenced a private offering (the "offering") of $1.0 billion aggregate principal amount of its sen...

4 weeks ago - PRNewsWire

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (4)

DaVita Inc. 2nd Quarter 2024 Results

DENVER , Aug. 6, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June30, 2024. "On behalf of all the teammates who provide life-saving car...

4 weeks ago - PRNewsWire

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (5)

DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call

DENVER , July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announcedtoday that it will hold its quarterly conference call to discuss second quarter results onTuesday, August 6, 2024, at5:00 p....

7 weeks ago - PRNewsWire

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (6)

Renal Denervation Devices Market Expected to Reach USD 387 Million by 2032 with a Remarkable 37.2% CAGR, According to Straits Research

Renal Denervation Devices Market Size, Share & Trends Analysis Report By Technology (Radiofrequency-based, Ultrasound-based, Micro-infusion-based, Others), By End User (Hospitals & Clinics, Ambulatory...

Other symbols: MDT

7 weeks ago - GlobeNewsWire

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (7)

US FTC probing DaVita, Fresenius Medical, Politico reports

The U.S. Federal Trade Commission (FTC) is investigating healthcare providers DaVita and Fresenius Medical Care over allegations that the companies have been illegally thwarting smaller competitors, P...

Other symbols: FMS

7 weeks ago - Reuters

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (8)

DaVita, Nuwellis Extend Pilot Collaboration for Aquadex

DaVita DVA recently extended the pilot phase of a previously announced supply and collaboration agreement with NuwellisNUWE until Aug 31, 2024.At the conclusion of the pilot phase, DaVita may extend ...

Other symbols: NUWE

3 months ago - Benzinga

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (9)

DaVita Celebrates Corporate Citizenship Achievements with Release of 2023 Community Care Report

DENVER , May 14, 2024 /PRNewswire/ --Today, DaVita(NYSE: DVA) published its 2023 Community Care Report, underscoring its dedication to corporate social responsibility and commitment to setting a new...

4 months ago - PRNewsWire

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (10)

DaVita Appoints New Chief Information Officer

Madhu Narasimhan named to leadership role to accelerate technology-based innovations at DaVita DENVER , May 13, 2024 /PRNewswire/ -- DaVita,a leading provider of kidney care services, today announce...

4 months ago - PRNewsWire

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (11)

DaVita Inc. to Participate in the BofA Securities 2024 Health Care Conference

DENVER , May 9, 2024 /PRNewswire/ --DaVita Inc.(NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will part...

4 months ago - PRNewsWire

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (12)

DaVita Honors 54 Nephrology Nurses with DAISY Awards

Award celebrates excellence in nursing, underscoring the kidney care provider's commitment to recognizing the indelible impact of clinicians on outstanding patient care DENVER , May 9, 2024 /PRNewswir...

4 months ago - PRNewsWire

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (13)

DaVita gains after upbeat quarterly profit prompts annual forecast raise

DaVita raised its annual profit forecast on Thursday banking on strong demand for its kidney dialysis services, sending its shares up 3.7% in trading after the bell.

4 months ago - Reuters

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (14)

DaVita Inc. 1st Quarter 2024 Results

DENVER , May 2, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March31, 2024. "Through the first quarter, we continued building on the mo...

4 months ago - PRNewsWire

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (15)

Best blue chip healthcare stocks to buy and hold in 2024

The healthcare industry is one of the biggest in the United States and other countries. In the US, the total Medicare expenditure stood at over $927 billion in 2022 and the trend is continuing as the ...

Other symbols: HCAISRG

4 months ago - Invezz

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (16)

DaVita's Global Operations Powered by 100% Renewable Energy

Kidney care provider enters virtual power purchase agreement in Spain after reaching 100% renewable energy goal in its North American operations DENVER , April 22, 2024 /PRNewswire/ -- By 2025, DaVit...

4 months ago - PRNewsWire

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (17)

DaVita Inc. Schedules 1st Quarter 2024 Investor Conference Call

DENVER , April 17, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announcedtoday that it will hold its quarterly conference call to discuss first quarter results onThursday, May 2, 2024, at5:00 p.m....

5 months ago - PRNewsWire

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (18)

DaVita Announces Dennis Pullin to its Board of Directors

DENVER , April 10, 2024 /PRNewswire/ -- DaVita Inc.today announcedthat its Board of Directors has appointed a new independent director, Dennis Pullin, to join the Board, effective April 10, 2024. "W...

5 months ago - PRNewsWire

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (19)

The American Diabetes Association and DaVita Strengthen Alliance to Tackle Chronic Disease Head-On

Efforts to advance chronic disease prevention through enhanced education, awareness and support — kicking off during National Kidney Month DENVER , March 11, 2024 /PRNewswire/ -- Today,The American D...

6 months ago - PRNewsWire

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (20)

DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2024

DENVER , March 8, 2024 /PRNewswire/ -- DaVita Inc.(NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will pa...

6 months ago - PRNewsWire

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (21)

DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador

Expansion would make DaVita the largest dialysis services provider in Latin America DENVER , March 5, 2024 /PRNewswire/ -- DaVita Inc (NYSE: DVA), a leading provider of kidney care services, today ann...

6 months ago - PRNewsWire

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (22)

DaVita Inc. to Participate in the TD Cowen's Health Care Conference 2024

DENVER , Feb. 29, 2024 /PRNewswire/ --DaVita Inc.(NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will pa...

6 months ago - PRNewsWire

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (23)

DaVita Stock Is Having Its Best Day in Years. Volumes Are Improving After Covid-19.

Dialysis provider DaVita reported fourth-quarter financials above Wall Street's consensus.

7 months ago - Barrons

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (24)

DaVita gains after co says expects strong 2024 profit

DaVita forecast 2024 profit above Wall Street estimates on Tuesday on anticipated strong demand for its kidney dialysis services, sending its shares up 4.8% after the bell.

7 months ago - Reuters

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (25)

DaVita Inc. 4th Quarter 2023 Results

DENVER , Feb. 13, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2023. "As we reflect on the past year, our 2023 fin...

7 months ago - PRNewsWire

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis (2024)

FAQs

DaVita Inc. (DVA) Stock Price, Quote & News - Stock Analysis? ›

The highest analyst price target is $165.00 ,the lowest forecast is $145.00. The average price target represents -6.76% Decrease from the current price of $163.56. DaVita's analyst rating consensus is a Hold. This is based on the ratings of 5 Wall Streets Analysts.

Is DVA stock a buy? ›

The highest analyst price target is $165.00 ,the lowest forecast is $145.00. The average price target represents -6.76% Decrease from the current price of $163.56. DaVita's analyst rating consensus is a Hold. This is based on the ratings of 5 Wall Streets Analysts.

What is DVA stock target? ›

Stock Price Targets
High$175.00
Median$150.00
Low$145.00
Average$155.86
Current Price$165.19

Is DaVita a good buy? ›

DVA has an average earnings surprise of 24.2%. With strong valuation and earnings metrics, a good Zacks Rank, and top-tier Value and VGM Style Scores, investors should strongly think about adding DVA to their portfolios.

How much dividend does DaVita pay per share? ›

Does DaVita pay dividends? We have never paid cash dividends and have no current plans to do so in the future.

Is DV a good stock to buy? ›

Is DV a Buy, Sell or Hold? DoubleVerify Holdings has a consensus rating of Moderate Buy which is based on 12 buy ratings, 3 hold ratings and 1 sell ratings.

Why is DaVita stock going up? ›

DaVita, carrying a Zacks Rank #1 (Strong Buy) at present, is witnessing an upward trend in its stock price, prompted by the company's business model. The optimism, led by a solid second-quarter 2024 performance and the acquisition of dialysis centers, is expected to contribute further.

Who owns the most DaVita stock? ›

Largest shareholders include Berkshire Hathaway Inc, Vanguard Group Inc, BlackRock Inc., State Street Corp, COWZ - Pacer US Cash Cows 100 ETF, VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, Invesco Ltd., VFINX - Vanguard 500 Index Fund Investor Shares, Morgan Stanley, and Geode Capital Management, Llc ...

What is the projected growth of DaVita? ›

Future Growth

DaVita is forecast to grow earnings and revenue by 2.3% and 3.6% per annum respectively. EPS is expected to grow by 9.9% per annum. Return on equity is forecast to be 139.5% in 3 years.

What is the yield of DVA stock? ›

Historical dividend payout and yield for DaVita (DVA) since 1971. The current TTM dividend payout for DaVita (DVA) as of September 11, 2024 is $0.00. The current dividend yield for DaVita as of September 11, 2024 is 0.00%.

Does Warren Buffett own DaVita dialysis? ›

Berkshire's stake in DaVita (NYSE: DVA) tops 41%. Its nearly 36.1 million shares of the dialysis services provider are currently worth close to $5 billion. Buffett first initiated a position in DaVita in the fourth quarter of 2011. He added to Berkshire's shares of DaVita regularly over the next three years.

How is DaVita doing financially? ›

Diluted earnings per share was $2.65 and adjusted diluted earnings per share was $2.38. Operating cash flow was $(135) million and free cash flow was $(327) million. Repurchased 2.1 million shares of our common stock at an average price paid of $112.76 per share.

Which is a better company DaVita or Fresenius? ›

Employee Ratings

DaVita scored higher in 4 areas: Culture & Values, Diversity & Inclusion, Career Opportunities and CEO Approval. Fresenius Medical Care scored higher in 5 areas: Overall Rating, Work-life balance, Senior Management, Compensation & Benefits and Recommend to a friend.

What stock pays the highest dividend? ›

10 Best Dividend Stocks to Buy
  • Verizon Communications VZ.
  • Chevron CVX.
  • Comcast CMCSA.
  • Medtronic MDT.
  • Dow DOW.
  • LyondellBasell Industries LYB.
  • Devon Energy DVN.
  • Hershey HSY.
Aug 30, 2024

Does Walgreens pay good dividends? ›

Dividend Data

Walgreens Boots Alliance, Inc.'s ( WBA ) dividend yield is 10.86%, which means that for every $100 invested in the company's stock, investors would receive $10.86 in dividends per year.

What percent dividend does Lowes pay? ›

LOW pays a dividend of $1.15 per share. LOW's annual dividend yield is 1.76%. When is Lowe's Companies ex-dividend date? Lowe's's upcoming ex-dividend date is on Oct 23, 2024.

Is Dominion stock a buy or sell? ›

Dominion Energy has a consensus rating of Hold which is based on 1 buy ratings, 9 hold ratings and 0 sell ratings. The average price target for Dominion Energy is $56.71. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.

Is VDC a buy or sell? ›

Is VDC a Buy, Sell or Hold? VDC has a consensus rating of Moderate Buy which is based on 59 buy ratings, 41 hold ratings and 6 sell ratings. What is VDC's price target?

Is vet stock a buy or sell? ›

Vermilion Energy has a consensus rating of Moderate Buy which is based on 5 buy ratings, 2 hold ratings and 0 sell ratings. The average price target for Vermilion Energy is C$20.74. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.

Is DS Smith a buy or sell? ›

Is DS Smith PLC a Buy, Sell or Hold? DS Smith PLC has a consensus rating of Hold, which is based on 1 buy ratings, 3 hold ratings and 0 sell ratings. What is DS Smith PLC's share price target? The average share price target for DS Smith PLC is 384.92p.

Top Articles
Latest Posts
Recommended Articles
Article information

Author: Kareem Mueller DO

Last Updated:

Views: 6157

Rating: 4.6 / 5 (66 voted)

Reviews: 81% of readers found this page helpful

Author information

Name: Kareem Mueller DO

Birthday: 1997-01-04

Address: Apt. 156 12935 Runolfsdottir Mission, Greenfort, MN 74384-6749

Phone: +16704982844747

Job: Corporate Administration Planner

Hobby: Mountain biking, Jewelry making, Stone skipping, Lacemaking, Knife making, Scrapbooking, Letterboxing

Introduction: My name is Kareem Mueller DO, I am a vivacious, super, thoughtful, excited, handsome, beautiful, combative person who loves writing and wants to share my knowledge and understanding with you.